Regen Lab

8 articles about Regen Lab

• Regen Lab partners with Morocco's Ministries of Health and Industry, Dassault Systèmes, Baylor College of Medicine (US) and SOTHEMA to accelerate regenerative medicine in Morocco and Africa

  7/7/2023

  Regen Lab announces the signing of a collaboration agreement with the Moroccan Ministries of Health and Industry, the Dassault Systèmes group, Baylor College of Medicine and the Moroccan Therapeutic Society, to create a fully integrated global operational structure dedicated to the deployment of regenerative medicine in Morocco and more widely in Africa.

• RegenLab USA LLC announces the signing of a collaboration agreement with Long Island University Brooklyn NYS, which hosts the "Dassault Systèmes Center of Excellence" to support research in regenerative medicine

  6/7/2023

  Regen Lab, a Swiss commercial-stage medical technology company specializing in the research, development, registration, manufacturing and commercialization of proprietary tissue engineering products announces that its US subsidiary, RegenLab USA LLC, has entered into a collaboration agreement with Long Island University (LIU) and the Dassault Systèmes Group (3DS).

• The ITC Complaint Against Estar Medical in the U.S. is Withdrawn by Regenlab

  3/5/2020

  According to the ITC's Office of Unfair Import Investigations, the Regenlab asserted U.S. patent is invalid and not infringed - RegenLab could not meet the requirements of a U.S. domestic industry..

• New U.S. Patents Granted for RegenLab - May 21, 2019

  5/21/2019

  Mr. Antoine Turzi, inventor, Regen Lab SA and RegenLab USA LLC are delighted to announce that the United States Patent and Trademark Office (USPTO) has issued two new U.S. patents covering its Thrombin Serum (TS), Platelet Rich Plasma (PRP) and Hyaluronic Acid (HA) technologies

• EPO Revokes Regenlab PRP Patent

  5/21/2019

  Estar Medical has been successful in revoking Regenlab's original PRP patent in the European Patent Office (EPO) opposition proceedings. This ruling follows a recent judgment by the UK High Court which also found the Regenlab PRP patent invalid for lack of novelty and inventive step, imposing Regenlab to pay hundreds of thousands of pounds to Estar Medical.

• New U.S. Patents Granted for RegenLab

  9/13/2018

  Mr. Antoine Turzi, inventor, Regen Lab SA and RegenLab USA LLC are delighted to announce that the United States Patent and Trademark Office (USPTO) has issued two new U.S. patents covering its Platelet Rich Plasma (PRP), Bone Marrow Concentrate (BMC) and Hyaluronic Acid (HA) technologies

• Regen Lab Presents The Latest Clinical Data On The Use Of Cellular Matrix Technology In Dermatology, Mixing The Patient's Platelet Rich Plasma With Hyaluronic Acid In A One-Step Closed System

  9/14/2017

• Regen Lab Admits Eclipse Aesthetics PRP Kit Does Not Infringe Regenlab Patent

  9/12/2017